Abstract
Helicobacter pylori (H. pylori) is a causative agent of gastrointestinal diseases such as atrophic gastritis and gastroduodenal ulcer. Infection of cagA-positive H. pylori is also associated with gastric carcinoma and gastric mucosa-associated lymphoid tissue (MALT) lymphoma. The cagA gene product CagA is directly injected into the bacteria-attached host cells via the bacterial type IV secretion system. The translocated CagA deregulates intracellular signaling pathways and thereby initiates pathogenesis. In this work, we examined the biological effects of CagA on B cells, from which MALT lymphoma arises. Ectopic expression of CagA in interleukin 3-dependent B cells inhibited cell proliferation by suppressing the JAK-STAT signaling. CagA was also capable of preventing hydroxyurea-induced B-cell apoptosis through inhibiting p53 accumulation. In contrast to the effects of CagA in gastric epithelial cells, the observed CagA activities in B cells were independent of its tyrosine phosphorylation. Our results indicate that CagA possesses both phosphorylation-dependent and -independent activities in mammalian cells and that biological impacts of CagA depend on cell-type context. As a result of B-cell growth inhibition, CagA may diminish anti-H. pylori immune responses. Furthermore, CagA may play a role in the development of MALT lymphoma by impairing p53-dependent apoptosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Auer IA, Gascoyne RD, Connors JM, Cotter FE, Greiner TC, Sanger WG and Horsman DE . (1997). Ann. Oncol., 8, 979–985.
Baens M, Maes B, Steyls A, Geboes K, Marynen P and De Wolf-Peeters C . (2000). Am. J. Pathol., 156, 1433–1439.
Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN and Nomura A . (1995). Cancer Res., 55, 2111–2115.
Dierlamm J, Baens M, Wlodarska I, Stefanova-Ouzounova M, Hernandez JM, Hossfeld DK, De Wolf-Peeters C, Hagemeijer A, Van den Berghe H and Marynen P . (1999). Blood, 93, 3601–3609.
Du MQ and Isaacson PG . (2002). Lancet Oncol., 3, 97–104.
Eck M, Schmausser B, Haas R, Greiner A, Czub S and Muller-Hermelink HK . (1997). Gastroenterology, 112, 1482–1486.
Flores-Morales A, Pircher TJ, Silvennoinen O, Gustafsson JA, Sanchez-Gomez M, Norstedt G, Haldosen LA and Wood TJ . (1998). Mol. Cell. Endocrinol., 138, 1–10.
Gartel AL and Shchors K . (2003). Exp. Cell Res., 283, 17–21.
Gouilleux F, Wakao H, Mundt M and Groner B . (1994). EMBO J., 13, 4361–4369.
Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M and Hatakeyama M . (2002). Science, 295, 683–686.
Hoshikawa Y, Amimoto K, Mizuguchi R and Hatakeyama M . (1998a). Anal. Biochem., 261, 211–218.
Hoshikawa Y, Mori A, Amimoto K, Iwabe K and Hatakeyama M . (1998b). Proc. Natl. Acad. Sci. USA, 95, 8574–8579.
Kuipers EJ, Thijs JC and Festen HP . (1995a). Aliment. Pharmacol. Ther., 9 (Suppl. 2), 59–69.
Kuipers EJ, Perez-Perez GI, Meuwissen SG and Blaser MJ . (1995b). J. Natl. Cancer Inst., 87, 1777–1780.
Kuipers EJ . (1997). Aliment. Pharmacol. Ther., 11 (Suppl. 1), 71–88.
Mui AL, Wakao H, Kinoshita T, Kitamura T and Miyajima A . (1996). EMBO J., 15, 2425–2433.
Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W and Haas R . (2000). Science, 287, 1497–1500.
Ott G, Katzenberger T, Greiner A, Kalla J, Rosenwald A, Heinrich U, Ott MM and Muller-Hermelink HK . (1997). Cancer Res., 15, 3944–3948.
Palacios C, Gutierrez del Arroyo A, Silva A and Collins MK . (2000). Oncogene, 19, 3556–3559.
Reddy EP, Korapati A, Chaturvedi P and Rane S . (2000). Oncogene, 19, 2532–2547.
Ross J . (1996). Trends Genet., 12, 171–175.
Selbach M, Moese S, Hauck CR, Meyer TF and Backert S . (2002). J. Biol. Chem., 277, 6775–6778.
Seoane J, Le HV and Massague J . (2002). Nature, 419, 729–734.
Sheu BS, Yang HB, Wu JJ, Huang AH, Lin XZ and Su IJ . (1999). Dig. Dis. Sci., 44, 868–875.
Silvennoinen O, Witthuhn BA, Quelle FW, Cleveland JL, Yi T and Ihle JN . (1993). Proc. Natl. Acad. Sci. USA, 90, 8429–8433.
Stein M, Bagnoli F, Halenbeck R, Rappuoli R, Fantl WJ and Covacci A . (2002). Mol. Microbiol., 43, 971–980.
Tsutsumi R, Higashi H, Higuchi M, Okada M and Hatakeyama M . (2003). J. Biol. Chem., 278, 3664–3670.
Wang X, Willen R, Andersson C and Wadstrom T . (2000). APMIS, 108, 503–508.
Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M and Isaacson PG . (1993). Lancet, 342, 575–577.
Acknowledgements
We thank Dr Yosuke Miura for technical help. We also thank members of the Hatakeyama Laboratory for their technical assistance and helpful discussions. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan, and by a grant of the Virtual Research Institute of Aging of Nippon Boehringer Ingelheim.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Umehara, S., Higashi, H., Ohnishi, N. et al. Effects of Helicobacter pylori CagA protein on the growth and survival of B lymphocytes, the origin of MALT lymphoma. Oncogene 22, 8337–8342 (2003). https://doi.org/10.1038/sj.onc.1207028
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207028
Keywords
This article is cited by
-
Helicobacter pylori cagA status and gastric mucosa-associated lymphoid tissue lymphoma: a systematic review and meta-analysis
Journal of Health, Population and Nutrition (2022)
-
Effect of Helicobacter pylori and Helminth Coinfection on the Immune Response to Mycobacterium tuberculosis
Current Microbiology (2021)
-
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
Scientific Reports (2017)
-
Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma
Journal of Hematopathology (2017)
-
The CagA toxin of Helicobacter pylori: abundant production but relatively low amount translocated
Scientific Reports (2016)